Spots Global Cancer Trial Database for glioblastoma multiforme (gbm)
Every month we try and update this database with for glioblastoma multiforme (gbm) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM | NCT02202993 | Glioblastoma Mu... | Mibefradil with... | 18 Years - 80 Years | Jazz Pharmaceuticals | |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme | NCT00730262 | Glioblastoma Mu... | TLN-4601 | 18 Years - | Thallion Pharmaceuticals | |
| TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM | NCT02202993 | Glioblastoma Mu... | Mibefradil with... | 18 Years - 80 Years | Jazz Pharmaceuticals | |
| Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA | NCT01238237 | Glioblastoma Mu... ANAPLASTIC ASTR... GBM Anaplastic Astr... | Superselective ... | 18 Years - | Northwell Health | |
| ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme | NCT04587830 | Glioblastoma Mu... | ADI-PEG20 Temozolomide | 20 Years - 75 Years | Polaris Group | |
| Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab | NCT01788280 | Glioblastoma Mu... | Fluciclitite , ... | 18 Years - | University of Utah | |
| Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab | NCT01788280 | Glioblastoma Mu... | Fluciclitite , ... | 18 Years - | University of Utah | |
| Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | NCT00671970 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) | NCT00615927 | Glioblastoma Gliosarcoma | Imatinib Mesyla... | 18 Years - | Duke University | |
| A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors | NCT04704154 | Solid Tumors | Regorafenib, (S... Nivolumab (Opdi... | 18 Years - | Bayer | |
| Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients | NCT02654041 | Glioblastoma Mu... | Combined T3 and... | 18 Years - | Musli Thyropeutics Ltd. | |
| UNITE Study: Understanding New Interventions With GBM ThErapy | NCT03419403 | Glioblastoma Mu... | Steroid eye dro... Vasoconstrictor... Cold compress Ophthalmic ster... Depatuxizumab m... Temozolomide Radiation | 18 Years - | AbbVie | |
| UNITE Study: Understanding New Interventions With GBM ThErapy | NCT03419403 | Glioblastoma Mu... | Steroid eye dro... Vasoconstrictor... Cold compress Ophthalmic ster... Depatuxizumab m... Temozolomide Radiation | 18 Years - | AbbVie | |
| Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | NCT00671970 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma | NCT02029573 | Glioblastoma Mu... | Atorvastatin Temozolomide Radiotherapy | 18 Years - 70 Years | King Fahad Medical City | |
| ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme | NCT04587830 | Glioblastoma Mu... | ADI-PEG20 Temozolomide | 20 Years - 75 Years | Polaris Group | |
| Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | NCT00671970 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors | NCT04704154 | Solid Tumors | Regorafenib, (S... Nivolumab (Opdi... | 18 Years - | Bayer | |
| Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma | NCT00354913 | Glioblastoma Gliosarcoma | hydroxyurea imatinib mesyla... | 18 Years - | Duke University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
